Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Vinorelbine in Advanced Soft Tissue Sarcoma
NCT00134641Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Feb 2003
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, vinorelbine in soft tissue sarcoma (STS), sponsored by Dana-Farber Cancer Institute. Started Feb 2003; status: completed.
02
Drugs
gemcitabinevinorelbine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00134641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134641.